Most Read Articles
Jairia Dela Cruz, 22 Apr 2020
A wristwatch-like device that monitors pulse, breathing and blood oxygen levels of the user allows physicians to provide care remotely both in hospital and nontraditional settings, and may help in the fight against the coronavirus disease 2019 (COVID-19) pandemic.
Roshini Claire Anthony, 27 May 2020

The use of a vaginal cleansing intervention prior to Caesarean delivery reduced the incidence of surgical site infections (SSIs), according to a study presented at ACOG 2020. However, the addition of intravenous (IV) azithromycin prophylaxis had no added impact on SSI rates. 

Pank Jit Sin, 21 May 2020

Persons suffering from asthma should pay particular attention to SARS-CoV-2 precautionary measures such as social distancing, regular handwashing, and wearing of masks on top of keeping their asthma in control. This is because data collected so far paints a bleaker picture for asthmatics than the normal population should they catch COVID-19.

Stephen Padilla, 28 May 2020
Herd immunity will not work in the novel coronavirus disease (COVID-19), according to an infectious disease expert who addressed over 3,600 primary care physicians (PCP) from Asia Pacific at the inaugural webcast of the MIMS COVID Conversations Series.

HPV infection bears increased risk of psoriasis

13 Apr 2020

Individuals with human papillomavirus (HPV) infection are at higher risk of psoriasis, with the risk increasing in accordance with age, a study has found.

The analysis included 66,274 patients with HPV infection and 265,096 controls without the infection. Those in the HPV vs control group were more likely to have comorbidities (except for diabetes and cerebrovascular accident) and have used nonsteroidal anti-inflammatory drugs (4.59 percent) or antihypertensive drugs (11.38 percent).

The incidence rate of psoriasis was markedly higher in the HPV than in the control group: 8.73 vs 4.39 per 100,000 person-months. Cox proportional hazards models revealed that HPV was associated with a heightened risk of developing the auto-immune disease (hazard ratio [HR], 1.177, 95 percent confidence interval [CI], 1.010–1.373).

There was a prominent interaction effect observed between age and HPV infection on the risk of developing psoriasis. Relative to those aged <20 years, individuals in the higher age groups had a greater risk. The HRs were 1.905 (95 percent CI, 1.577–2.302) in the 20–39 years, 2.319 (95 percent CI, 1.901–2.830) in the 40–59 years, and 2.970 (95 percent CI, 2.330–3.785) in the ≥60 years age groups.

Furthermore, men had a slightly higher risk of psoriasis than women (HR, 1.653, 95 percent CI, 1.464–1.866).

In light of the findings, the researchers urged clinicians to provide appropriate monitoring of the high-risk groups for psoriasis, in addition to treating their HPV infection.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Infectious Diseases - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Jairia Dela Cruz, 22 Apr 2020
A wristwatch-like device that monitors pulse, breathing and blood oxygen levels of the user allows physicians to provide care remotely both in hospital and nontraditional settings, and may help in the fight against the coronavirus disease 2019 (COVID-19) pandemic.
Roshini Claire Anthony, 27 May 2020

The use of a vaginal cleansing intervention prior to Caesarean delivery reduced the incidence of surgical site infections (SSIs), according to a study presented at ACOG 2020. However, the addition of intravenous (IV) azithromycin prophylaxis had no added impact on SSI rates. 

Pank Jit Sin, 21 May 2020

Persons suffering from asthma should pay particular attention to SARS-CoV-2 precautionary measures such as social distancing, regular handwashing, and wearing of masks on top of keeping their asthma in control. This is because data collected so far paints a bleaker picture for asthmatics than the normal population should they catch COVID-19.

Stephen Padilla, 28 May 2020
Herd immunity will not work in the novel coronavirus disease (COVID-19), according to an infectious disease expert who addressed over 3,600 primary care physicians (PCP) from Asia Pacific at the inaugural webcast of the MIMS COVID Conversations Series.